Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;476(2):1179-1193.
doi: 10.1007/s11010-020-03981-7. Epub 2020 Nov 16.

Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization

Affiliations

Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization

Relja Suručić et al. Mol Cell Biochem. 2021 Feb.

Abstract

The search for effective coronavirus disease (COVID-19) therapy has attracted a great deal of scientific interest due to its unprecedented health care system overload worldwide. We have carried out a study to investigate the in silico effects of the most abundant pomegranate peel extract constituents on the multi-step process of serious acute respiratory syndrome coronavirus 2 (SARS-CoV-2) internalization in the host cells. Binding affinities and interactions of ellagic acid, gallic acid, punicalagin and punicalin were studied on four selected protein targets with a significant and confirmed role in the process of the entry of virus into a host cell. The protein targets used in this study were: SARS-CoV-2 spike glycoprotein, angiotensin-converting enzyme 2, furin and transmembrane serine protease 2. The results showed that the constituents of pomegranate peel extracts, namely punicalagin and punicalin had very promising potential for significant interactions with the selected protein targets and were therefore deemed good candidates for further in vitro and in vivo evaluation.

Keywords: COVID-19; Molecular docking; Pomegranate peel extract; Punicalagin; Punicalin; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The author(s) declare that there is no conflict of interest.

Figures

Fig. 1
Fig. 1
Chemical structure of the most abundant components of the pomegranate peel extract
Fig. 2
Fig. 2
Selected active sites of analysed protein targets; (a) S glycoprotein, (b) ACE2, (c) Furin and (d) TMPRSS2
Fig. 3
Fig. 3
Amino acid frequencies at targets predicted active sites of S glycoprotein, ACE2, furin and TMPRSS2 proteins (ACE2- angiotensin converting enzyme 2; TMPRSS2 – transmembrane serine protease 2)
Fig. 4
Fig. 4
S glycoprotein amino acids involved in interactions with selected PoPEx ligands and positive controls
Fig. 5
Fig. 5
ACE2 amino acids involved in interactions with selected PoPEx ligands and positive controls
Fig. 6
Fig. 6
Furin amino acids involved in interactions with selected PoPEx ligands and sulconazole
Fig. 7
Fig. 7
TMPRSS2 amino acids involved in interactions with selected PoPEx ligands and camostat

References

    1. Coronaviridae Study Group of the International Committee on Taxonomy of V The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–544. doi: 10.1038/s41564-020-0695-z. - DOI - PMC - PubMed
    1. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523–534. doi: 10.1038/nrmicro.2016.81. - DOI - PMC - PubMed
    1. Aćimović J, Jandrić L, Đakovic-Dević J, Bojanić J, Subotić B, Radojčić T, Rodić-Vukmir N, Zeljković B. Epidemiological characteristics of COVID-19 infection in the Republic of Srpska: a hundred days survey. Scr Med. 2020;51:74–80. doi: 10.5937/scriptamed51-27298. - DOI
    1. Jiang S, Hillyer C, Du L. Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses. Trends Immunol. 2020;41:355–359. doi: 10.1016/j.it.2020.03.007. - DOI - PMC - PubMed
    1. Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD (2020) SARS-CoV-2 and coronavirus disease 2019: what we know so far. Pathogens 9. 10.3390/pathogens9030231 - PMC - PubMed

MeSH terms

LinkOut - more resources